MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$46,639,000
EPS
-$0.13
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
0
0
5,485,000
0
Research and development
38,636,000
33,809,000
24,952,000
25,745,000
General and administrative
12,146,000
9,677,000
8,833,000
8,279,000
Impairment of long-lived assets
-
-
0
0
Net gain on lease termination
3,433,000
-
-
-
Total operating expenses
47,349,000
43,486,000
33,785,000
34,024,000
Loss from operations
-47,349,000
-43,486,000
-28,300,000
-34,024,000
Change in fair value of warrant liability
0
0
736,000
292,000
Change in fair value of term loan
1,521,000
1,470,000
1,643,000
1,534,000
Interest income
2,325,000
2,586,000
2,870,000
3,169,000
Interest expense
6,000
9,000
12,000
15,000
Other expense
-88,000
-31,000
-30,000
-37,000
Total other income (expense), net
710,000
1,076,000
449,000
1,291,000
Net loss
-46,639,000
-42,410,000
-27,851,000
-32,733,000
Basic EPS
-0.13
-0.12
-0.078
-0.09
Diluted EPS
-0.13
-0.12
-0.078
-0.09
Basic Average Shares
369,044,040
366,632,827
358,243,055
353,309,524
Diluted Average Shares
369,044,040
366,632,827
358,243,055
353,309,524
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Interest income$2,325,000 (25.07%↑ Y/Y)Net loss-$46,639,000 (-73.50%↓ Y/Y)Total other income(expense), net$710,000 (650.39%↑ Y/Y)Change in fair value ofterm loan$1,521,000 (4.11%↑ Y/Y)Other expense-$88,000 (62.87%↑ Y/Y)Interest expense$6,000 (-64.71%↓ Y/Y)Loss from operations-$47,349,000 (-76.99%↓ Y/Y)Total operatingexpenses$47,349,000 (64.76%↑ Y/Y)Net gain on leasetermination$3,433,000 Research and development$38,636,000 (91.83%↑ Y/Y)General andadministrative$12,146,000 (41.27%↑ Y/Y)

Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies, Inc. (TSHA)